A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection

A new vectored vaccine MVA-VLP-SUDV was generated against Sudan ebolavirus (SUDV) combining the advantages of the immunogenicity of a live attenuated vaccine vector (Modified Vaccinia Ankara, MVA) with the authentic conformation of virus-like particles (VLPs). The vaccine expresses minimal component...

Descripción completa

Detalles Bibliográficos
Autores principales: Malherbe, Delphine C., Domi, Arban, Hauser, Mary J., Atyeo, Caroline, Fischinger, Stephanie, Hyde, Matthew A., Williams, Julie M., Alter, Galit, Guirakhoo, Farshad, Bukreyev, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314403/
https://www.ncbi.nlm.nih.gov/pubmed/35879311
http://dx.doi.org/10.1038/s41541-022-00512-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314403/
https://www.ncbi.nlm.nih.gov/pubmed/35879311
http://dx.doi.org/10.1038/s41541-022-00512-x

Ejemplares similares